Over the next several years, GSK expects to increase supply of Shingrix globally and is investing in significant capacity expansion. Shingrix is currently licensed for use in the EU, US, Canada, Japan …
United Kingdom : GSK announces approval of Shingrix in China for prevention of shingles in adults aged 50 and over
United Kingdom : GSK announces approval of Shingrix in China for prevention of shingles in adults aged 50 and over
Leave a reply